Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial
Top Cited Papers
Open Access
- 1 April 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (4) , 666-668
- https://doi.org/10.1038/mt.2010.31
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The promise and potential pitfalls of chimeric antigen receptorsCurrent Opinion in Immunology, 2009
- Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell TherapyJournal of Immunotherapy, 2009
- Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia XenograftsClinical Cancer Research, 2007
- Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15Nature Medicine, 2003
- Targeting tumours with genetically enhanced T lymphocytesNature Reviews Cancer, 2003
- Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptorNature Biotechnology, 2002